Branching Out: DEP® Dendrimer Nanoparticles as a Versatile Platform for Precision Cancer Radiotheranostics
Time: 1:45 pm
day: Day 1 - Track A (PM)
Details:
• Starpharma’s polylysine DEP® dendrimers for development of radiotheranostic pairs
• Utility of DEP® platform for targeted delivery of radiotheranostics
• Overview of DEP® HER2-targeted radiotheranostics
